It is a leading biotech company focused on immunology-related therapeutic areas.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 1, 2021 | Series C | $100M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kunlun Fund | — | Series C |